Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Carla L. Alves, Sidse Ehmsen, Mikkel G. Terp, Neil Portman, Martina Tuttolomondo, Odd L. Gammelgaard, Monique F. Hundebøl, Kamila Kaminska, Lene E. Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik J. Ditzel
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Science Q
Accès en ligne:	https://doaj.org/article/df7e78eab9c643b4bcc917eea8a3ff30
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:df7e78eab9c643b4bcc917eea8a3ff30
record_format	dspace
spelling	oai:doaj.org-article:df7e78eab9c643b4bcc917eea8a3ff302021-12-02T18:33:48ZPublisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer10.1038/s41467-021-25901-z2041-1723https://doaj.org/article/df7e78eab9c643b4bcc917eea8a3ff302021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25901-zhttps://doaj.org/toc/2041-1723Carla L. AlvesSidse EhmsenMikkel G. TerpNeil PortmanMartina TuttolomondoOdd L. GammelgaardMonique F. HundebølKamila KaminskaLene E. JohansenMartin BakGabriella HonethAna BoschElgene LimHenrik J. DitzelNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Carla L. Alves Sidse Ehmsen Mikkel G. Terp Neil Portman Martina Tuttolomondo Odd L. Gammelgaard Monique F. Hundebøl Kamila Kaminska Lene E. Johansen Martin Bak Gabriella Honeth Ana Bosch Elgene Lim Henrik J. Ditzel Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
format	article
author	Carla L. Alves Sidse Ehmsen Mikkel G. Terp Neil Portman Martina Tuttolomondo Odd L. Gammelgaard Monique F. Hundebøl Kamila Kaminska Lene E. Johansen Martin Bak Gabriella Honeth Ana Bosch Elgene Lim Henrik J. Ditzel
author_facet	Carla L. Alves Sidse Ehmsen Mikkel G. Terp Neil Portman Martina Tuttolomondo Odd L. Gammelgaard Monique F. Hundebøl Kamila Kaminska Lene E. Johansen Martin Bak Gabriella Honeth Ana Bosch Elgene Lim Henrik J. Ditzel
author_sort	Carla L. Alves
title	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_short	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_full	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_fullStr	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_full_unstemmed	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
title_sort	publisher correction: co-targeting cdk4/6 and akt with endocrine therapy prevents progression in cdk4/6 inhibitor and endocrine therapy-resistant breast cancer
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/df7e78eab9c643b4bcc917eea8a3ff30
work_keys_str_mv	AT carlalalves publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT sidseehmsen publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT mikkelgterp publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT neilportman publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT martinatuttolomondo publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT oddlgammelgaard publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT moniquefhundebøl publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT kamilakaminska publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT leneejohansen publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT martinbak publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT gabriellahoneth publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT anabosch publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT elgenelim publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT henrikjditzel publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer
_version_	1718377951391645696

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Documents similaires